|
|
|
|
| First Name: | Hager | | Last Name: | Al-Serougi | | Title: | Assistant lecturer | | Advanced Degrees: | master degree | | Affiliation: | Misr University for Science and Technology | | Department: | Physical Therapy for Neurological Disorders and its Surgery | | City: | Nasr city | | State/Province: | Cairo | | Zip/Postal Code: | 11371 | Country/Territory: | Egypt | | Phone: | 01006021558 | | Email Address: |  |
Disclosure:
(view policy)
|
Member reports no financial or other potential conflicts of interest. [Last Modified: 30 March 2012]
|
Polyglutamine Disorders (Huntington's, etc.), Parkinson Disease, Stroke and Trauma, Alzheimer Disease, Neuromuscular Disorders (ALS, etc.)
|
Oxidative Stress, Genetics, Neuropathology, Clinical trials, Neurotransmission, Epidemiology
|
My name is Hager Rasmi Al-serougi.. Am 31 years old. I work as an assistant lecturer in the department of physical therapy for neurological and neurosurgical disorders, faculty of physical therapy, Misr university for science and Technology, Egypt. Am also a licensed physical therapy specialist her in Egypt. My masters degree was about how we can assess postural instability in Parkinson's disease patients objectively so that we can design the appropriate physical therapy program for each patient. Am hoping now that i will start |
1- Influence of Somatosensory and Motor Systems on Postural Stability in Parkinson’s disease Patients |
am guessing that we still miss alot of knowledge in various aspects of neurodegenerative disease... |
1- Test-Retest Reliability and Minimal Detectable Change Scores for the Timed “Up & Go” Test, the Six-Minute Walk Test, and Gait Speed in People With Alzheimer Disease Julie D. Ries, John L. Echternach, Leah Nof and Michelle Gagnon Blodgett Physical Therapy June 2009 vol. 89 no. 6 569-579 2-A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease The Baltimore Longitudinal Study of Aging C. Kawas, S. Resnick, A. Morrison, R. Brookmeyer, M. Corrada, A. Zonderman, C. Bacal, PA-C, D. Donnell Lingle and E. Metter, June 1, 1997 vol. 48 no. 6 1517-1521
3-A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease Mark H Tuszynski, Leon Thal, Mary Pay, David P Salmon, Hoi Sang U, Roy Bakay4, Piyush Patel5, Armin Blesch, H Lee Vahlsing1, Gilbert Ho1, Gang Tong1, Steven G Potkin, James Fallon, Lawrence Hansen1, Elliott J Mufson, Jeffrey H Kordower, Christine Gall & James Conner Nature Medicine 11, 551 - 555 (2005) |
I would like to peruse research in Alzheimer disease and try to answer alot of questions regarding that topic.. for example if certain blood biomarkers can be identified and can be measured pre and post the administration of a certain therapy (which i wish to be physical exercise and cognitive/ perceptual training) to see if there will be any improvement. Also i wish i could include a very large population sample that will cover different age groups (people with no cognitive problems, ones who are at risk of identifying cognitive impairment (based on gene analysis) and those with already symptoms of cognitive impairment. another part is answer the question regarding race, hey have effects on AD sex (male and females), diet etc do they have and effect on AD....Brain plasticity is also an issue i would like to address in AD and in any other neurological disorders... |
Physical therapy (physical activity and cognitive training)can have a tremendous effect on the welfare of the cognitive function in those at risk of AD and those already manifesting symptoms of mild AD.
Brain Imaging will prove that improvement in the hippocampal are after administering training in both groups
|
I wish to prove that cognitive dysfunction has a solution (and a simple) one which doesn't require expensive medications. Just by education those at risk or those already having the symptoms we can make a difference.
Also i wish that i can really prove that blood biomarkers can be considered as an investigation of choice in identifying AD instead of invasive procedure such as CSF tap. |
My fall back position will be i guess neural plasticity a i mentioned previously in different neurological disorders...
|
|
|
|
|
|
|